The ACAT inhibitor HL-004 inhibits cholesterol absorption and lowers serum cholesterol in rats

General Pharmacology

Volumn 31, Issue 4, 1998, Pages 593-596

  Asami, Yumiko ^a   Kondo, Yukiko ^a   Murakami, Shigeru ^a   Araki, Hiroaki ^a   Tsuchida, Katsuharu ^a   Higuchi, Shohei ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

ACAT (acyl CoA:cholesterol acyltransferase); ACAT inhibitor; Cholesterol fed rat; HL 004

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; N (2,6 DIISOPROPYLPHENYL)TETRADECYLTHIOACETAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DRUG EFFECT; HYPOCHOLESTEROLEMIA; INTRAGASTRIC DRUG ADMINISTRATION; LIPID ABSORPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ABSORPTION; ACETANILIDES; ANIMALS; ANTICHOLESTEREMIC AGENTS; BODY WEIGHT; CHOLESTEROL; FISTULA; LIVER; RATS; RATS, WISTAR; STEROL O-ACYLTRANSFERASE;

EID: 0032189209     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(98)00046-9     Document Type: Article

References (18)

1. Bennett Clark S., Tercyak A.M. Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function. J. Lipid Res. 25:1984;148-159.
2. Carr T.P., Hamilton R.L. Jr., Rudel L.L. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J. Lipid Res. 36:1995;25-36.
3. Cianflone K.M., Yasruel Z., Rodriguez M.A., Vas D., Sniderman A.D. Regulation of apoB secretion from Hep G2 cells; evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J. Lipid Res. 31:1990;2045-2055.
4. Devon C.A., Engelhorn S.C., Steinberg D. Secretion of very low density lipoproteins enriched in cholesteryl esters by cultured rat hepatocytes during stimulation of intracellular cholesterol esterification. J. Lipid Res. 21:1980;1065-1071.
5. Field F.J., Cooper A.D., Erickson S.K. Regulation of rabbit intestinal acyl coenzyme A-cholesterol acyltransferase in vivo and in vitro. Gastroenterology. 83:1982;873-880.
6. Heider J.G., Pickens C.E., Kelly L.A. Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J. Lipid Res. 24:1983;1127-1134.
7. Hirose T., Suzuki A., Iida I., Tanaka S., Tsulamoto M., Yamaguchi J., Watanabe Y., Ogawa N., Fukushima K. Metabolic fate of TS-962, a new ACAT inhibitor. Xenobiot. Metabol. Dispos. 12(suppl.):1997;272.
8. Ikeda I., Tomari Y., Sugano M., Watanabe S., Nagata J. Lymphatic absorption of structured glycerolipids containing medium-chain fatty acids and linoleic acid, and their effect on cholesterol absorption in rats. Lipids. 26:1991;369-373.
9. Krause B.R., Anderson M., Bisgaier C.L., Bocan T., Bousley R., DeHart P., Essenburg A., Hamelehle K., Homan R., Kieft K., McNally W., Stanfield R., Newton R.S. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT. J. Lipid Res. 34:1993;279-294.
10. Murakami S., Ohta Y., Asami Y., Yamagishi I., Toda Y., Sato M., Tomisawa K. The hypolipidemic action of the ACAT inhibitor HL-004 in hamsters fed normal chow. Gen. Pharmac. 27:1996;1383-1386.
11. Murakami S., Yamagishi I., Sato M., Tomisawa K., Nara Y., Yamori Y. ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP). stimulation of bile acid production by HL-004 Atherosclerosis. 133:1997;97-101.
12. Sakuma Y., Hagihara H., Ohne K., Nagayoshi A., Mutoh S., Ito Y., Notsu Y., Okuhara M. Plasma cholesterol reducing effect of FR129169, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in the rat. Jpn. J. Pharmac. 70:1996;35-41.
13. Salé Omodeo F., Marchesini S., Fishman P.H., Berra B. A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal. Biochem. 142:1984;347-350.
14. Spector A.A., Mathur S.N., Kaduce T.L. Role of acylcoenzyme A:cholesterol O-acyltransferase in cholesterol metabolism. Prog. Lipid Res. 18:1979;31-53.
15. Suckling K.E., Stange E.F. Role of acyl-CoA:cholesterol acyl-transferase in cellular cholesterol metabolism. J Lipid Res. 26:1985;647-671.
16. Sugiyama Y., Ishikawa E., Odaka H., Miki N., Tawada H., Ikeda H. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters. Atherosclerosis. 113:1995;71-78.
17. Tanaka H., Ohtsuka I., Kogushi M., Kimura T., Fujimori T., Saeki T., Hayashi K., Kobayashi H., Yamada T., Hiyoshi H., Saito I. Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits. Atherosclerosis. 107:1994;187-201.
18. Yanagita T., Sonda K., Yamamoto K., Yotsumoto H., Murakami S. Effect of a new acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor HL-004 on cholesterol esterification and lipid metabolism in HepG2 cells. Curr. Ther. Res. 56:1995;787-795.